摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

diethylene glycol monobutyl ether tosylate | 50964-16-4

中文名称
——
中文别名
——
英文名称
diethylene glycol monobutyl ether tosylate
英文别名
3,6-dioxadecyl p-toluenesulfonate;2-(2-butoxyethoxy)ethyl tosylate;2-(2-butoxyethoxy)-ethyl tosylate;2-(2-Butoxy-ethoxy)-ethyl-p-toluolsulfonat;2-(2-Butoxyethoxy)ethyl 4-methylbenzenesulfonate
diethylene glycol monobutyl ether tosylate化学式
CAS
50964-16-4
化学式
C15H24O5S
mdl
——
分子量
316.419
InChiKey
UVHCZQYWUFAXOI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    21
  • 可旋转键数:
    11
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    70.2
  • 氢给体数:
    0
  • 氢受体数:
    5

SDS

SDS:195bb102143a21165841294407d66b22
查看

反应信息

点击查看最新优质反应信息

文献信息

  • Pyrazolo[4,3-d]pyrimidine derivative, process for its production,
    申请人:Nissan Chemical Industries Ltd.
    公开号:US04654348A1
    公开(公告)日:1987-03-31
    A pyrazolo[4,3-d]pyrimidine derivative having the formula: ##STR1## wherein R.sup.1 is lower alkyl or phenyl, R.sup.2 is --A--CO.sub.2 R.sup.21 (wherein A is alkylene having from 1 to 10 carbon atoms which is unsubstituted or substituted by alkyl having from 1 to 3 carbon atoms; and R.sup.21 is lower alkyl having from 1 to 4 carbon atoms), --CH.sub.2 CO-phenyl, a saturated or unsaturated, straight chain or branched aliphatic group having from 3 to 16 carbon atoms, phenyl-lower alkyl, --CH.sub.2 CN, chloro substituted phenyl-lower alkyl or ##STR2## (wherein R.sup.22 is hydrogen or lower alkyl), and R.sup.3 is a saturated or unsaturated, straight chain or branched aliphatic group having from 2 to 22 carbon atoms, phenyl-lower alkyl, benzyloxy substituted phenyl-lower alkyl, lower alkyl substituted or unsubstituted 2-(phenylmethyloxy)ethyl, cyclohexylcyclohexyl, methylcyclohexyl, 3-thia-n-heptyl, 3,6-dioxa-n-decyl, 4-oxo-n-pentyl or 2-hydroxyethyl. Intermediates and processes of making the compounds of formula I are also disclosed. The compounds of formula I are useful as antihyperlipidemic agents.
    一种具有以下结构的吡唑并[4,3-d]嘧啶生物:##STR1##其中R.sup.1是较低的烷基或苯基,R.sup.2是--A--CO.sub.2R.sup.21(其中A是具有1至10个碳原子的未取代或取代的烷基,取代基为具有1至3个碳原子的烷基;R.sup.21是具有1至4个碳原子的较低烷基),--CH.sub.2CO-苯基,具有3至16个碳原子的饱和或不饱和、直链或支链脂肪族基团,苯基-较低烷基,--CH.sub.2CN,取代的苯基-较低烷基或##STR2##(其中R.sup.22是氢或较低烷基),R.sup.3是具有2至22个碳原子的饱和或不饱和、直链或支链脂肪族基团,苯基-较低烷基,苄氧基取代的苯基-较低烷基,取代或未取代的2-(苯基甲氧基)乙基,环己基环己基,甲基环己基,3-代-n-庚基,3,6-二氧-n-癸基,4-氧代-n-戊基或2-羟乙基。还公开了制备式I化合物的中间体和工艺。式I化合物可用作抗高脂血症药物。
  • [EN] OXAZINE-BASED WATER-SOLUBLE FLUOROPHORE COMPOUNDS FOR IN VIVO NERVE IMAGING<br/>[FR] COMPOSÉS FLUOROPHORES HYDROSOLUBLES À BASE D'OXAZINE POUR IMAGERIE NERVEUSE IN VIVO
    申请人:UNIV OREGON HEALTH & SCIENCE
    公开号:WO2021138116A1
    公开(公告)日:2021-07-08
    This invention provides novel oxazine-based, water soluble fluorophore compounds useful in in vivo nerve imaging, as well as compositions comprising them and methods for their use.
    这项发明提供了一种新型的氧杂环丙啶基溶性荧光物质化合物,可用于体内神经成像,以及包含它们的组合物和使用方法。
  • [EN] NERVE-SPECIFIC FLUOROPHORE FORMULATIONS FOR DIRECT AND SYSTEMIC ADMINISTRATION<br/>[FR] FORMULATIONS DE FLUOROPHORE SPÉCIFIQUES AUX NERFS POUR UNE ADMINISTRATION DIRECTE ET SYSTÉMIQUE
    申请人:UNIV OREGON HEALTH & SCIENCE
    公开号:WO2021158820A1
    公开(公告)日:2021-08-12
    Nerve-specific fluorophore formulations of Formula (I) for direct or systemic administration are described. The formulations can be used in fluorescence-guided surgery (FGS) to aid in nerve preservation during surgical interventions.
    描述了用于直接或全身给药的Formula (I)的神经特异性荧光素配方。这些配方可用于在手术干预过程中辅助神经保护的荧光引导手术(FGS)中。
  • Substituted alkynyl phenoxy compounds and their uses
    申请人:Endura S.p.a.
    公开号:EP2289889A1
    公开(公告)日:2011-03-02
    An alkynyl phenoxy compound of Formula (I) is described, wherein R1 and R2, similar or different, are (C1-C4)alkyl or R1O- and R2O- together represent a group -O-CH2-O-, -O-CH(CH3)-O-, -O-CH2-CH2-O-, -O-CH2-CH2-, R3 is (C1-C6)alkyl, (C3-C6)alkenyl or -B-(CH2-CH2-O)z-R6 where B is -CH2-O- or -O-, z is 0, 1 or 2 and R6 is (C1-C4)alkyl; R4 is hydrogen or methyl;R5 is hydrogen or methyl;x is an integer from 1 to 2; y is 0,1 or 2; with the proviso that when R3 is -B-(CH2-CH2-O)2-R6, y is 1 and 5-(propargyloxy)-benzo[1,3]dioxole is excluded. A pesticide composition comprising the compound of the invention and a pesticidal active ingredient is also described.
    描述一种Formula (I)的炔基苯氧化合物,其中R1和R2,相似或不同,是(C1-C4)烷基或R1O-和R2O-一起表示一个基团 -O-CH2-O-, -O-CH(CH3)-O-, -O- - -O-, -O- - -, R3是(C1-C6)烷基,(C3-C6)烯基或-B-( - -O)z-R6,其中B是- -O-或-O-, z是0, 1或2,R6是(C1-C4)烷基;R4是氢或甲基;R5是氢或甲基;x是1到2之间的整数;y是0,1或2;但是当R3是-B-( - -O)2-R6时,y为1,并排除5-(丙炔氧基)-苯并[1,3]二噁英。还描述了包括该发明化合物和杀虫活性成分的杀虫剂组合物。
  • [EN] SUBSTITUTED ALKYNYL PHENOXY COMPOUNDS AS NEW SYNERGISTS IN PESTICIDAL COMPOSITIONS<br/>[FR] COMPOSÉS D'ALCYNYL-PHÉNOXY SUBSTITUÉS EN TANT QUE NOUVEAUX SYNERGISTES DANS DES COMPOSITIONS PESTICIDES
    申请人:ENDURA SPA
    公开号:WO2011020848A1
    公开(公告)日:2011-02-24
    A composition comprising an alkynyl phenoxy compound of Formula (I) as a synergist and a pesticidal active ingredient is described, wherein R1 and R2, similar or different, are (C1-C4)alkyl or R1O- and R2O- together represent a group -O-CH2-O-, -O- CH(CH3)-O, -O-CH2-CH2-O-, -O-CH2-CH2-, R3 is (C1-C6)alkyl, (C3-C6)alkenyl or -B- (CH2-CH2-O)z-R6 where B is -CH2-O- or -O-, z is 0, 1 or 2 and R6 is (C1-C4)alkyl;R4 is hydrogen or methyl;R5 is hydrogen or methyl;x is an integer from 1 to 2; y is 0, 1 or 2; with the proviso that when R3 is -B-(CH2-CH2-O)z-R6, y is 1 and 5-(propargyloxy)- benzo[1,3]dioxole is excluded.
    描述了一种包括化学式(I)中的炔基苯氧化合物作为协同剂和杀虫活性成分的组合物,其中R1和R2,相似或不同,为(C1-C4)烷基或R1O-和R2O-一起代表一个基团-O-CH2-O-,-O- CH(CH3)-O,-O- - -O-,-O- - -,R3为(C1-C6)烷基,(C3-C6)烯基或-B-( - -O)z-R6,其中B为- -O-或-O-,z为0、1或2,R6为(C1-C4)烷基;R4为氢或甲基;R5为氢或甲基;x为1至2的整数;y为0、1或2;但当R3为-B-( - -O)z-R6时,y为1,且排除5-(丙炔氧基)-苯并[1,3]二噁烷
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫